Table 2.
Domain/question | Simple | Complicated | Complex | |
Domain 1: The condition or illness | ||||
1A. What is the nature of the condition or illness? | Well-characterized, well-understood, predictable | Not fully characterized, understood, or predictable | Poorly characterized, poorly understood, unpredictable, or high risk | |
1B. What are the relevant sociocultural factors and comorbidities? | Unlikely to affect care significantly | Must be factored into care plan and service model | Pose significant challenges to care planning and service provision | |
Domain 2: The technology | ||||
2A. What are the key features of the technology? | Off-the-shelf or already installed, freestanding, dependable | Not yet developed or fully interoperable; not 100% dependable | Requires close embedding in complex technical systems; significant dependability issues | |
2B. What kind of knowledge does the technology bring into play? | Directly and transparently measures [changes in] the condition | Partially and indirectly measures [changes in] the condition | Link between data generated and [changes in] the condition is currently unpredictable or contested | |
2C. What knowledge and/or support is required to use the technology? | None or a simple set of instructions | Detailed instruction and training needed, perhaps with ongoing helpdesk support | Effective use of technology requires advanced training and/or support to adjust to new identity or organizational role | |
2D. What is the technology supply model? | Generic, “plug and play,” or COTSa solutions requiring minimal customization; easily substitutable if supplier withdraws | COTS solutions requiring significant customization or bespoke solutions; substitution difficult if supplier withdraws | Solutions requiring significant organizational reconfiguration or medium- to large scale-bespoke solutions; highly vulnerable to supplier withdrawal | |
Domain 3: The value proposition | ||||
3A. What is the developer’s business case for the technology (supply-side value)? | Clear business case with strong chance of return on investment | Business case underdeveloped; potential risk to investors | Business case implausible; significant risk to investors | |
3B. What is its desirability, efficacy, safety, and cost effectiveness (demand-side value)? | Technology is desirable for patients, effective, safe, and cost effective | Technology’s desirability, efficacy, safety, or cost effectiveness is unknown or contested | Significant possibility that technology is undesirable, unsafe, ineffective, or unaffordable | |
Domain 4: The adopter system | ||||
4A. What changes in staff roles, practices, and identities are implied? | None | Existing staff must learn new skills and/or new staff be appointed | Threat to professional identity, values, or scope of practice; risk of job loss | |
4B. What is expected of the patient (and/or immediate caregiver)—and is this achievable by, and acceptable to, them? | Nothing | Routine tasks, eg, log on, enter data, converse | Complex tasks, eg, initiate changes in therapy, make judgments, organize | |
4C. What is assumed about the extended network of lay caregivers? | None | Assumes a caregiver will be available when needed | Assumes a network of caregivers with ability to coordinate their input | |
Domain 5: The organization | ||||
5A. What is the organization’s capacity to innovate? | Well-led organization with slack resources and good managerial relations; risk taking encouraged | Limited slack resources; suboptimal leadership and managerial relations; risk taking not encouraged | Severe resource pressures (eg, frozen posts); weak leadership and managerial relations; risk taking may be punished | |
5B. How ready is the organization for this technology-supported change? | High tension for change, good innovation-system fit, widespread support | Little tension for change; moderate innovation-system fit; some powerful opponents | No tension for change; poor innovation-system fit; many opponents, some with wrecking power | |
5C. How easy will the adoption and funding decision be? | Single organization with sufficient resources; anticipated cost savings; no new infrastructure or recurrent costs required | Multiple organizations with partnership relationship; cost-benefit balance favorable or neutral; new infrastructure (eg, staff roles, training, kit) can mostly be found from repurposing | Multiple organizations with no formal links and/or conflicting agendas; funding depends on cost savings across system; costs and benefits unclear; new infrastructure conflicts with existing; significant budget implications | |
5D. What changes will be needed in team interactions and routines? | No new team routines or care pathways needed | New team routines or care pathways that align readily with established ones | New team routines or care pathways that conflict with established ones | |
5E. What work is involved in implementation and who will do it? | Established shared vision; few simple tasks, uncontested and easily monitored | Some work needed to build shared vision, engage staff, enact new practices, and monitor impact | Significant work needed to build shared vision, engage staff, enact new practices, and monitor impact | |
Domain 6: The wider context | ||||
6A. What is the political, economic, regulatory, professional (eg, medicolegal), and sociocultural context for program rollout? | Financial and regulatory requirements already in place nationally; professional bodies and civil society supportive | Financial and regulatory requirements being negotiated nationally; professional and lay stakeholders not yet committed | Financial and regulatory requirements raise tricky legal or other challenges; professional bodies and lay stakeholders unsupportive or opposed | |
Domain 7: Embedding and adaptation over time | ||||
7A. How much scope is there for adapting and coevolving the technology and the service over time? | Strong scope for adapting and embedding the technology as local need or context changes | Potential for adapting and coevolving the technology and service is limited or uncertain | Significant barriers to further adaptation and/or coevolution of the technology or service | |
7B. How resilient is the organization to handling critical events and adapting to unforeseen eventualities? | Sense making, collective reflection, and adaptive action are ongoing and encouraged | Sense making, collective reflection, and adaptive action are difficult and viewed as low priority | Sense making, collective reflection, and adaptive action are discouraged in a rigid, inflexible implementation model |
aCOTS: customizable, off-the-shelf.